These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25369654)

  • 1. Effectiveness of experimental whole-cell pertussis vaccines in murine model.
    Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Lutyńska A
    Med Dosw Mikrobiol; 2014; 66(2):79-87. PubMed ID: 25369654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland.
    Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Guiso N; Lutyńska A
    Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):155-60. PubMed ID: 25297678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.
    Prygiel M; Mosiej E; Wdowiak K; Górska P; Polak M; Lis K; Krysztopa-Grzybowska K; Zasada AA
    Med Microbiol Immunol; 2021 Dec; 210(5-6):251-262. PubMed ID: 34338880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
    Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
    Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
    Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
    Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959-2013.
    Mosiej E; Krysztopa-Grzybowska K; Polak M; Prygiel M; Lutyńska A
    J Med Microbiol; 2017 Jun; 66(6):753-761. PubMed ID: 28598302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
    Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
    Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
    Kallonen T; Gröndahl-Yli-Hannuksela K; Elomaa A; Lutyńska A; Fry NK; Mertsola J; He Q
    Infect Genet Evol; 2011 Dec; 11(8):2034-42. PubMed ID: 21964035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines.
    Queenan AM; Fernandez J; Shang W; Wiertsema S; van den Dobbelsteen GP; Poolman J
    Expert Rev Vaccines; 2014 Oct; 13(10):1265-70. PubMed ID: 25029905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.
    Mosiej E; Augustynowicz E; Zawadka M; Dabrowski W; Lutyńska A
    J Clin Microbiol; 2011 Apr; 49(4):1452-7. PubMed ID: 21307213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
    Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP
    Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis in Argentina and France.
    Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
    Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
    Mills KH; Brady M; Ryan E; Mahon BP
    Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.